Skip to navigation
Skip to content
Skip to sidebar

Drug Pricing Policy Watch

Schulwolf_Erik

Posted on June 1st, 2017 by Foley Hoag

Copyright © 2019, Foley Hoag LLP. All rights reserved.

Categories: Comments Trackbacks

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Home
About
Contact
Archives

Search

Blog Authors

Pat Cerundolo
Pat Cerundolo’s highly diverse administrative law, litigation and regulatory practice involves representing both private and public sector clients in a variety of local...More
Stephen L. Bartlett
Steve Bartlett is an associate in the firm’s Administrative Law Department, where he counsels clients on health care, real estate and government related concerns...More
Erik L. Schulwolf
Erik Schulwolf is an Associate in Foley Hoag’s Administrative Department. He works on health care and infrastructure and construction matters, among others...More
View All Authors »

About Us

Foley Hoag lawyers and healthcare specialists have decades of experience in statutory and regulatory analysis, healthcare compliance, government investigations, litigation and corporate transactions ...More

Subscribe to BlogRSS

ADD THIS BLOG to your feeds or enter your e-mail in the box below and hit GO to subscribe by e-mail.

Join»Our Mailing List

See»Our publications

Topics

All Payers
Cost Control
Government Payers
Legislative Developments
Private Price Commitments
Transparency

Links

Foley Hoag LLP
Advertising & Marketing Law
Cannabis & The Law
Corporate Social Responsibility & The Law
Energy & Cleantech Counsel
IPO, Then What?
Law & The Environment
Massachusetts Labor & Employment Law
Massachusetts Noncompete Law
Medicaid & The Law
Security, Privacy & The Law
State AG Insights
Trademark & Copyright Law
White Collar Law & Investigations

Recent Updates

Massachusetts Senate Ways and Means Budget Maintains Drug Price Rebate Language
Massachusetts House Pushes Medicaid Supplemental Rebate Law in Budget
Maryland Forges Ahead on Drug Price Transparency
Massachusetts Senate Passes Bill Aiming to Increase Drug Price Transparency and Notification Obligations
PhRMA Mounts Legal Challenge to SB 17 in California

Privacy Policy
Disclaimer

Copyright © 2019, Foley Hoag LLP. All rights reserved.

Boston
Seaport West
155 Seaport Boulevard
Boston, MA 02210-2600
contact@foleyhoag.com
tel: 617 832 1000
fax: 617 832 7000

New York
1301 Avenue of the Americas
New York, NY 10019
contact@foleyhoag.com
tel: 646 927 5500
fax: 646 927 5599

Washington D.C.
1875 K Street., N.W.
Washington, D.C. 20006-1238
contact@foleyhoag.com
tel: 202 223 1200
fax: 202 785 6687

Foley Hoag AARPI
153 rue du Faubourg Saint-Honoré
75008 Paris, France
contact@foleyhoag.com
tel: +33 (0)1 70 36 61 30
fax: +33 (0)1 70 36 61 31

Drug Pricing Policy Watch

Published by Foley Hoag LLP

Attorney advertising.
Prior results do not guarantee a similar outcome.